Navigation Links
Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
Date:9/10/2007

Plan Cost Advisor helps consumers determine out-of-pocket health care costs

CAMP HILL, Pa., Sept. 10 /PRNewswire/ -- Highmark Blue Shield has introduced a new tool to help consumers compare health plan options and choose one that best suits their needs. The Plan Cost Advisor is available to consumers on Highmark member Web sites.

"Choosing a health plan is often intimidating to consumers," said Kim Bellard, Vice President of eMarketing and Customer Relationship Management. "This is especially true now that consumers are more likely to be faced with not just increased cost-sharing but also various types of tax-preferred spending accounts, such as health savings accounts (HSAs). The Plan Cost Advisor helps consumers model their estimated out-of-pocket spending for the different health plan options they may have."

To begin using the Plan Cost Advisor, consumers enter basic information about family, health conditions and health plan options. Plan Cost Advisor analyzes the information that is entered by the consumer and projects the next year's medical spending for each health plan option with a breakdown for copays, deductibles and coinsurance.

The tool then shows consumers estimated out-of-pocket spending, taking into account any payroll contributions as well as any benefit cost-sharing for each health plan option entered. Plan Cost Advisor also helps users with HSAs or other spending accounts model the impacts of various contributions to the account.

"Highmark was a pioneer in giving consumers online tools to help them more effectively select the right health plan when we introduced BlueChoice in May 2000," said Bellard. "Plan Cost Advisor further leverages our consumerism expertise and our health analytics capabilities to produce an additional way for consumers to have a greater hand in their health care decisions."

Highmark has an ongoing commitment to its members to give them tools to make the right health care decisions. Hig
'/>"/>

SOURCE Highmark Blue Shield
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Vitamin Shields Brittle Bones
2. Lead With a Poisonous Electron Shield
3. Sioux Herb Confirmed as Shield Against Colds
4. E Merck introduces Livogen Z with zinc sulphate
5. TI Cycles Introduces Foldman
6. Canada Introduces Mandatory Nutrition Labeling
7. Amgen introduces Autoinjector For Treating Anemia
8. Cuba Introduces New Device for Detecting Vascular Diseases
9. China Introduces Solar-powered Baths
10. Allergan Introduces ‘Dermal Filler’ for Smile Lins
11. UAE Introduces Cervical Cancer Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ould lead mothers to overlook needed care, study f...ews) -- A mother,s depression can worsen her child... six-month study of 262 black mothers and their ch...depressive symptoms had more frequent asthma sympt...ve symptoms had less frequent asthma symptoms. ,...
(Date:11/25/2009)...RNewswire/-- MISSIONSkincare ®isproudtosuppor...partofGNC,sannualSt.Jude ThanksandGiving campaign,...ew SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addi...5or$10donationatcheckoutatoneoftheir5,000+retaillo...nforSt.Judeduringtheir2009 ThanksandGiving campaig...
(Date:11/25/2009)...cancer vaccine carried into the body on a carefull...t to successfully eliminate tumors in mammals, sci...ranslational Medicine . , The new approach, pion... University, uses plastic disks impregnated with t...n to reprogram the mammalian immune system to atta...
(Date:11/25/2009)...der the skin kill tumor cells, study finds , ...ncer vaccine delivered in a fingernail-size implan...reports. , The method uses polymer disks, 8.5 m...-specific antigens and implanted under the skin to... Harvard University scientists who developed the i...
(Date:11/25/2009)... Initiative expands to include cost-effective, su..., and healthcare professionals in developing world...) November 25, 2009 -- Elluminate, Inc. , the lea...lutions that support 21st century teaching, learn...Fire and Ice initiative was awarded iNACOL,s fir...
Breaking Medicine News(10 mins):Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
... today announced the acquisition of Taylor Benefit...on were not disclosed., Established in 1996, Tayl...t consultation and brokerage services for their We...ngs accounts, health,reimbursement arrangements an...
...Feb. 18 The following is being,issued by the Chic...iety (CDS) recently polled more than 300,dentists ...ts seeking,braces, and how the current presidentia...are a few of the leading,tips for expectant mother...
...ralia,(MLA) has selected IMTEC Corporation to deve...stock carcasses. Using IMTEC,s 3D imaging,technolo...se 1 of a,multi-year, 6 phase process for objectiv...d other quality attributes., "IMTEC is very excit...
...tional organization formed to halt the US governme... holding a press conference in Wichita, Kansas,out...papers asking for an,emergency order to protect Ka...mplet ,e.zip, Siobhan Reynolds, President of the ...
...ht, scientists from the National Institute of Stan...o at Boulder have shown that they can detect molec...or cancer. , While the new technique has yet to b...arch team from JILA, a joint institute of NIST and...
...s, Inc. (Nasdaq: ONXX ) today announced that it w...ovide an update on Nexavar(R),(sorafenib) tablets,...r,2007 financial results, on Tuesday, February 19,...ial results for the,fourth quarter and year ended ...
Other Medicine News:Health News:Dentists' Top Five Oral Health Care Tips During Pregnancy 2Health News:IMTEC to Become Technology Solutions Provider for Meat & Livestock Australia 2Health News:Pain Relief Network Sues to Halt Government Actions Taken Against Kansas Patients 2Health News:Scientists using laser light to detect potential diseases via breath samples, says new study 2Health News:Scientists using laser light to detect potential diseases via breath samples, says new study 3Health News:Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled 2
(Date:11/24/2009)... ,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WH...r23yearsfollowinganautoaccident,wasactuallyfullyco...odMorningAmericasegment.TheDynaVoxEyeMaxwasfeature...dromeandotherconditionscanunlockcommunication. ,...ailableonlineat www.dynavoxtech.com ,, W...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--A...odaythatitwillpresentatthe21stAnnualPiperJaffrayHe...m.EST(6:00a.m.PST).TheconferenceisbeingheldatTheNe...iefExecutiveOfficerofAnadys,willprovideanoverviewo...ANA773. ,, Thecorporatepresentationwillbesimult...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24/PRNewswire/--Accumetrics...fyNow®System,thefirstrapidandeasy-to-usediagn...tipleantiplateletagents(e.g.Plavix®andaspirin...ofAccumetrics,andGregoryJ.Tibbitts,ChiefFinancialO...viewatthe21stAnnualPiperJaffrayHealthCareConferenc...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 1Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 4Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 1Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 1China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 3
...ial Expected to Initiate in 2010 for Blinatumomab ... MITI ), a biopharmaceutical company developing no...ancer, inflammation and autoimmune diseases, today...nalysts at The Yale Club of New York City. , , ... development across Micromet,s BiTE antibody platf...
... Presented Today at 44th Annual Meeting of EASL , ... Status During Q1 Financial Results Call at 5 P.M....aceuticals, Inc. (Nasdaq: ANDS ) today announced...cleoside polymerase inhibitor, demonstrated potent...l tolerated in a Phase Ib study in which patients ...
Other Medicine Technology:Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8
Pure Eyes
Graether Collar Button
Lobob Hard Lens Soaking Solutions
Crawford Fascia Stripper
Medicine Products: